Final Flashcards
Procedure Selection Bias
When healthy patients are given one treatment over another which results in the inflation of good qualities towards the treatment
Fix: randomization
Post Entry Exclusion
When the exclusion criteria is changed after the data has been seen
Fix: no post hoc changes
Selective Loss of Data
Caused when there is data missing resulting in a difference in the population. Effects vary depending on what the mechanism of missing is.
Assessment Bias
When the physician overestimates or underestimates a condition based upon the exposure or group of the individual
Fix: mask
Ascertainment Bias
When one group is sampled more or in greater detail relating to their illness or treatment group
Fix: mask
Single Mask
Patient doesn’t know treatment
Double Masking
Patient and be physician do not know the status of the individual
Triple mask
Patient doctor and DMC do not know the groups. This works best for objective testing of the stopping point so as not to favor one group over another.
Concurrent Trials
Eliminates the time effect of the study that would be found in historical controls. Eliminates the differences in selection criteria and time treatment
Active Follow Up
Follow up patient who drop out to make sure that there is no mechanism of why one group quits more.
Drop In
Patients who should have been in the control are in the treatment (p)
Drop Out
Patients who should have been in the treatment group are given the placebo
SS calculation win drop in and drop out
N=N*/[(1-p-q)^2(1-r)]
Cross Over Design
Repeated measure longitudinal study where the patient will receive both treatments. Subject to bias if there is a crossover effect.
Binary Cross Over Null
p12-p21=0
This is the off diagonal of the patients who showed a preference to one treatment over another
McNemars Test of Cross Over
Binomial(.5, n10+n01)
The null is that the preferential response is random with a frequency of 50%
Factorial Design
Only test that can test interaction effects the interaction effect can be removed afterwards unless one reverses another.
Incomplete Factorial
There is no placebo. Used to test is a combination of drugs is better than each of the mono therapies.
Null: one is better than the combination
Alt: the combination is better than both of the other two
Adaptive Design
Allows for a change in the study design, statistics, sample size, treatment, hypothesis, power, and end points
Very flexible
Sequential Analysis
SS is not fixed at start but while data is collected till a predefined stopping rule is reached. Lowers the over all cost
Can be done for futility, safety, superiority, or cost reasons
Conditional Power
It is the probability of getting statistically significant results given the trend in data
Drop the Loser Design
The inferior treatment group is dropped at a interim analysis and the population groups are changed to allow for new testing. Power is determined after second stage
Interim Analysis
Data dependent stopping or continuation. Check to see if null can be accepted or rejected. Also allows stopping for new literature
Continuation alleys for increase in precision and power
Type I Error
The probability of rejecting a null that is true. Overall type one error should be kept below .05
aT=1-(1-a1)(1-a2)…. Or aT=1-(1-a)^n